Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 17.52% vs -44.21% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 16.26% vs -38.94% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 22.22% vs 80.00% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Altimmune, Inc. With
Quarterly - Net Sales
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 17.52% vs -44.21% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -15.31% vs 19.67% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 16.26% vs -38.94% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -11.01% vs 18.35% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 22.22% vs 80.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025






